Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

150 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Glomerular filtration rate estimation in renal transplant patients based on serum cystatin-C levels: comparison with other markers of glomerular filtration rate.
Visvardis G, Griveas I, Zilidou R, Papadopoulou D, Mitsopoulos E, Kyriklidou P, Manou E, Ginikopoulou E, Meimaridou D, Pavlitou A, Sakellariou G. Visvardis G, et al. Among authors: papadopoulou d. Transplant Proc. 2004 Jul-Aug;36(6):1757-9. doi: 10.1016/j.transproceed.2004.06.009. Transplant Proc. 2004. PMID: 15350470
Therapeutic apheresis of immune diseases in nephrology department.
Visvardis G, Manou E, Griveas I, Meimaridou D, Mitsopoulos E, Kyriklidou P, Papadopoulou D, Ginikopoulou E, Rottstein L, Sakellariou G. Visvardis G, et al. Among authors: papadopoulou d. Ren Fail. 2004 Sep;26(5):569-74. doi: 10.1081/jdi-200031742. Ren Fail. 2004. PMID: 15526917
Acute hepatitis C in patients receiving hemodialysis.
Griveas I, Germanidis G, Visvardis G, Morice Y, Perelson AS, Pawlotsky JM, Papadopoulou D. Griveas I, et al. Among authors: papadopoulou d. Ren Fail. 2007;29(6):731-6. doi: 10.1080/08860220701460160. Ren Fail. 2007. PMID: 17763169
Immunosuppressive regimens based on Cyclophospamide or Calcineurin inhibitors: Comparison of their effect in the long term outcome of Primary Membranous Nephropathy.
Stangou M, Marinaki S, Papachristou E, Kolovou K, Sambani E, Zerbala S, Papadea P, Balafa O, Rapsomanikis KP, Andrikos A, Manolakaki P, Papadopoulou D, Mitsopoulos E, Liakou H, Andronikidi PE, Choulitoudi V, Moustakas G, Galitsiou D, Dafnis E, Stylianou K, Stefanidis I, Golfinopoulos S, Panagoutsos S, Tsilivigkou M, Papadogianakis A, Tzanakis I, Sioulis A, Vlachakos D, Grapsa E, Spaia S, Kaperonis N, Paliouras C, Dioudis C, Papoulidou F, Apostolou T, Iatrou C, Boletis I, Goumenos D, Papagianni A. Stangou M, et al. Among authors: papadopoulou d. PLoS One. 2019 Aug 12;14(8):e0217116. doi: 10.1371/journal.pone.0217116. eCollection 2019. PLoS One. 2019. PMID: 31404062 Free PMC article.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Nowack C, Kolkhof P, Ferreira AC, Schloemer P, Filippatos G; on behalf of the FIDELIO-DKD study investigators; FIDELIO-DKD study investigators. Bakris GL, et al. Am J Nephrol. 2019;50(5):333-344. doi: 10.1159/000503713. Epub 2019 Oct 25. Am J Nephrol. 2019. PMID: 31655812 Free PMC article. Clinical Trial.
150 results